CKD Clinical Trial
Official title:
Screening of Gastrointestinal Tract Bleeding Causes Among Chronic Renal Failure Patients in Assuit University in a Single Study Center
The aim of the current study is to screen different causes and characteristics of Gastrointestinal bleeding in Chronic Renal Failure patients at Assuit University Hospital according to their stages based on e GFR (Stage I to IV), in order to assess different modalities of therapeutic intervention from medical therapy up to therapeutic intervention.
- Chronic Renal Failure is defined as presence of reduced glomerular filtration rate (GFR)
< 60 ml/min/ 1.73 m2 and/or evidence of kidney damage (usually indicated by albuminuria
or proteinuria) for > 3 months or more irrespective of cause (Kiapidou et al., 2019).
- Chronic Renal Failure stages are classified according to the National Kidney Foundation
in to five stages according to estimated GFR (Ikizler 2009).
- The prevalence of Chronic Renal Failure is continuously rising in concert with the
rising epidemic of its risk factors including ageing, diabetes, obesity, metabolic
syndrome, smoking, and hypertension (Stevens and Levin 2013).
- Gastrointestinal bleeding, is all forms of bleeding in the gastrointestinal tract, from
the mouth to the rectum. When there is significant blood loss over a short time,
symptoms may include vomiting red blood, vomiting black blood, bloody stool, or black
stool. Small amounts of bleeding over a long time may cause iron-deficiency anemia
resulting in feeling tired or heart-related chest pain.
Other symptoms may include abdominal pain, shortness of breath, pale skin, or passing out.
Sometimes in those with small amounts of bleeding no symptoms may be present. (Bong Sik
Matthew Kim. 2014)
• Preliminary data suggest an association between Chronic Renal Failure and Gastrointestinal
Bleeding. Individuals with even mild to moderate Chronic Renal Failure warrant clinical
attention regarding the risk of hospitalization with Gastrointestinal bleeding. (Kunihiro
Matsushita, 2016 Oct 7) reported that the prevalence of Gastrointestinal bleeding was
significantly higher in patients with Chronic Renal Failure compared to patients without
Chronic Renal Failure.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03277911 -
Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney Diseases
|
N/A | |
Active, not recruiting |
NCT04008810 -
Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease
|
||
Completed |
NCT05144971 -
StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
|
||
Active, not recruiting |
NCT05356325 -
FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
|
||
Completed |
NCT04709120 -
Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
|
||
Terminated |
NCT03277183 -
Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin
|
Phase 4 | |
Enrolling by invitation |
NCT04491227 -
Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
|
||
Recruiting |
NCT06279429 -
Sucrosomial Iron on Insomnia in Non-dialysis Chronic Kidney Disease Patients With Iron Deficiency Anemia
|
N/A | |
Recruiting |
NCT03501745 -
Smart-CKD/BP Study
|
N/A | |
Recruiting |
NCT04708743 -
The Tongue Features Associated With Chronic Kidney Disease
|
||
Recruiting |
NCT06416761 -
Genetics in the Progression of Nephropathies
|
||
Completed |
NCT04119570 -
CKD Report Card Pilot Trial
|
N/A | |
Completed |
NCT06374043 -
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
|
Phase 4 | |
Not yet recruiting |
NCT06094920 -
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
|
Phase 4 | |
Recruiting |
NCT04819217 -
Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease
|
N/A | |
Completed |
NCT05970094 -
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
|
N/A | |
Withdrawn |
NCT04782297 -
Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)
|
||
Recruiting |
NCT05784389 -
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
|
N/A | |
Recruiting |
NCT04630132 -
Renal Ageing-sarcopenia Network
|
||
Not yet recruiting |
NCT06143098 -
Some Hematological Profile in Children With Chronic Kidney Disease
|